Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023 - 2026)

Contineum Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.7 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 77.06% year-over-year to 0.7 in Q1 2026; TTM through Mar 2026 was 2.78, a 72.19% increase from a year earlier, with the FY2025 full-year figure at 1.42, up 0.88% from the prior year.
• Interest Coverage Ratio grew to 0.7 in Q1 2026 per CTNM's latest filing, from 20.06 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 335.66 in Q2 2023 and bottomed at 135.29 in Q4 2024.
• The 4-year median for Interest Coverage Ratio is 3.06 (2025), against an average of 12.63.
• Across the five-year window, Interest Coverage Ratio surged 99.34% in 2024 and slumped 733.87% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 335.66 in 2023, then slumped by 140.31% to 135.29 in 2024, then jumped by 85.17% to 20.06 in 2025, then jumped by 96.5% to 0.7 in 2026.
• Per Business Quant, the three latest CTNM Interest Coverage Ratio figures stand at 0.7 (Q1 2026), 20.06 (Q4 2025), and 0.75 (Q3 2025).